Clinical Trial

AI in Endoscopic Transsphenoidal Surgery

Not Yet Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
This study focuses on bringing artificial intelligence into the operating room to assist with pituitary tumour surgeries performed through the nose. These procedures are technically demanding, and training new surgeons is often inconsistent. To address this, researchers at the National Hospital for Neurology and Neurosurgery are testing AI systems that "watch" surgical videos in real-time to identify anatomy, instruments, and the specific phase of the operation. The core goal of the prospective trial is to improve education and team coordination without interfering with the surgery itself. The AI displays its analysis on tablets positioned for the surgical residents and nurses, rather than the lead surgeon. This setup allows the team to follow the procedure's progress, key anatomy and anticipate next steps without the surgeon needing to stop and explain. Because hospital internet can be unreliable, the study is prioritizing specialized hardware from NVIDIA that processes data locally. This "edge computing" approach ensures the AI is fast and doesn't require a live cloud connection to function. This trial will assess the device feasibility (IDEAL Stage 1 study, \~6 cases), followed by early safety and system technical refinement (IDEAL 2a study, \~20-30 cases).
Trial Details
NCT Number NCT07568366
Lead Sponsor University College, London
Collaborators: University College London Hospitals
Conditions Pituitary Adenoma
Enrollment 30 participants
Start Date 2026-06-01
Primary Completion 2028-08-01 (estimated)
Study Completion 2029-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-05